Eris Lifesciences Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 727 | 705 | 773 | 792 | 807 | 757 | 873 | 892 | |
| 4 | 8 | 3 | 3 | 0.02 | 2 | 2 | 3 | |
| 616 | 584 | 615 | 623 | 645 | 598 | 696 | 703 | |
| 69 | 68 | 70 | 83 | 106 | 68 | 94 | 108 | |
| 133 | 96 | 104 | 146 | 117 | 123 | 131 | 168 | |
| −26 | 6 | 10 | −26 | 0.21 | −6 | 14 | −50 | |
| 125 | 121 | 144 | 137 | 138 | 137 | 153 | 149 | |
| 57 | 54 | 49 | 50 | 49 | 46 | 47 | 46 | |
| 81 | 77 | 71 | 69 | 70 | 70 | 72 | 73 | |
| 175 | 161 | 167 | 164 | 164 | 161 | 184 | 208 | |
| 255 | 260 | 279 | 291 | 264 | 276 | 299 | 277 | |
| 173 | 183 | 209 | 222 | 194 | 206 | 227 | 203 | |
| — | — | — | — | −17 | — | — | −36 | |
| 116 | 129 | 160 | 172 | 145 | 161 | 180 | 157 | |
| 29 | 27 | 36 | 38 | 37 | −120 | 36 | −31 | |
| 87 | 102 | 125 | 134 | 109 | 279 | 143 | 187 | |
| Financial ratios | ||||||||
| 34.99% | 36.91% | 36.14% | 36.73% | 32.74% | 36.45% | 34.20% | 31.00% | |
| 11.95% | 14.51% | 16.18% | 16.97% | 13.48% | 36.89% | 16.41% | 20.97% | |
| 6.15 | 6.90 | 8.66 | 8.82 | 7.32 | 20.60 | 10.28 | 13.26 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.